HIV Infections Clinical Trials in New York, New York

5 studies are recruiting for hiv infections in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

   The clinical schedule will consist of 3 injections of CD40.HIVRI.Env (VRIPRO) at weeks 0, 4, and 24.40 volunteers without HIV and in overall good health, aged 18 to 60 years, who previously participated in the HVTN 706 trial.

   Stage

   Phase 1

   Ages

   18 to 60

   Site

   Columbia P&S CRS, New York, New York

   Locations

   9 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT06665646 on ClinicalTrials.gov

2. Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples

   This study utilizes a randomized controlled trial design to evaluate the efficacy of couples motivational interviewing (MI) to reduce the frequency and severity of illicit drug use and frequency of HIV transmission risk behavior (TRB). Participants are randomized to one of two conditions: couples M…

   Stage

   Not phased

   Ages

   18 to 55

   Site

   Hunter College, New York, New York

   Locations

   3 in total

   Run by

   Hunter College of City University of New York

   See if you can join NCT06307977 on ClinicalTrials.gov

3. Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

   The goal of this observational study is to generate real-life information on the use of lenacapavir (LEN, YEZTUGO®, (YTG)) for pre-exposure prophylaxis (PrEP) across diverse clinical settings in the United States. The study will characterize how PrEP is initiated, used, and discontinued in routine …

   Stage

   Not phased

   Ages

   18 and older

   Site

   NYC Health + Hospitals / Bellevue, New York, New York

   Locations

   38 in total

   Run by

   Gilead Sciences

   See if you can join NCT07473778 on ClinicalTrials.gov

4. An Effectiveness Trial of the PrEP for WINGS Study

   (Effectiveness Aim 1) To test the comparative effectiveness of PreP for WINGS versus PrEP alone on primary outcomes of increasing PrEP initiation measured by self-report/medical records, recent adherence and longer-term adherence by self-report/medical records over the 6-month follow-up; and second…

   Stage

   Not phased

   Ages

   18 and older

   Site

   The Columbia Community Partnership for Health, New York, New York

   Run by

   Columbia University

   See if you can join NCT06853314 on ClinicalTrials.gov

5. The TAIL-PrEP Study

   The goal of the TAIL-PrEP study is to understand how to support the safe discontinuation of injectable long-acting cabotegravir (cab-LA) and lenacapavir (LEN) while maximizing the public health impact of biomedical HIV prevention interventions. In Aim 1, the study will pilot test and assess the acc…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York, New York

   Run by

   Columbia University

   See if you can join NCT06868641 on ClinicalTrials.gov